Kane Biotech, Inc.

Kane Biotech, Inc.

Sector: Commercial Physical And Biological Research Region: Canada

: | OTC Markets: KNBIF | TSX Venture Exchange: KNE

Similar to: Exelixis, Inc., Medivir AB, Cerep SA

Kane Biotech, Inc. is a biotechnology company engaged in the development and commercialization of products to prevent and remove biofilms. Biofilms are a major cause of a number of serious medical problems, including chronic infections and medical device related infections. The company was founded on May 17, 2001 and is headquartered in Winnipeg, Canada.

News & Analysis

You may also be interested in: